<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ikonomidis, Ignatios</style></author><author><style face="normal" font="default" size="100%">Athanassopoulos, George</style></author><author><style face="normal" font="default" size="100%">Stamatelopoulos, Kimon</style></author><author><style face="normal" font="default" size="100%">Lekakis, John</style></author><author><style face="normal" font="default" size="100%">Revela, Ioanna</style></author><author><style face="normal" font="default" size="100%">Venetsanou, Kiriaki</style></author><author><style face="normal" font="default" size="100%">Marinou, Margarita</style></author><author><style face="normal" font="default" size="100%">Monaco, Claudia</style></author><author><style face="normal" font="default" size="100%">Cokkinos, Dennis V</style></author><author><style face="normal" font="default" size="100%">Nihoyannopoulos, Petros</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Additive prognostic value of interleukin-6 at peak phase of dobutamine stress echocardiography in patients with coronary artery disease. A 6-year follow-up study</style></title><secondary-title><style face="normal" font="default" size="100%">American heart journal</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2008</style></year></dates><number><style face="normal" font="default" size="100%">2</style></number><publisher><style face="normal" font="default" size="100%">Mosby</style></publisher><volume><style face="normal" font="default" size="100%">156</style></volume><pages><style face="normal" font="default" size="100%">269–276</style></pages><language><style face="normal" font="default" size="100%">eng</style></language></record></records></xml>